CTS-1027 in Interferon-Naive Hepatitis C Patients

ClinicalTrials.gov ID: NCT00925990

Public ClinicalTrials.gov record NCT00925990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 5, 2026, 9:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial of CTS-1027 in Interferon-Naive Hepatitis C Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is intended to determine whether CTS-1027 either alone or in combination with ribavirin is safe and effective in Hepatitis C patients who have not previously been treated with interferon.

Study identification

NCT ID: NCT00925990
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Conatus Pharmaceuticals Inc.; Industry
Enrollment: 70 participants

Conditions and interventions

Conditions

Hepatitis C

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 31, 2009
Primary completion: Apr 30, 2010
Completion: Jun 30, 2010
Last update posted: Mar 26, 2012

2009 – 2010

United States locations

U.S. sites: 20
U.S. states: 15
U.S. cities: 18

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35294	—
Medical Associates Research Group	San Diego	California	92123	—
Kaiser Permanante	San Diego	California	92154	—
VA Medical Center, San Diego	San Diego	California	92161	—
University of Colorado Health Science Center	Denver	Colorado	80262	—
Washington Hospital Center	Washington D.C.	District of Columbia	20010	—
University of Florida	Gainsville	Florida	32610	—
Tulane University Health Sciences Center	New Orleans	Louisiana	70112	—
University of MA Mem Med Ctr	Worchester	Massachusetts	01655	—
Henry Ford Medical Center-Columbus	Novi	Michigan	48377	—
MN Clinical Research Center	Plymouth	Minnesota	55446	—
Mayo Clinic Rochester	Rochester	Minnesota	55905	—
St. Louis University	St Louis	Missouri	63104	—
Mount Sinai School of Medicine	New York	New York	10029	—
University of NC at Chapel Hill	Chapel Hill	North Carolina	27599	—
Duke University Health System	Durham	North Carolina	27710	—
Consultants of Clinical Research, Ohio GI and Liver Institute	Cincinnati	Ohio	45219	—
Cleveland Clinic	Cleveland	Ohio	44195	—
VA Medical Center, Houston	Houston	Texas	77030	—
VCU-Medical College of Virginia	Richmond	Virginia	23298	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00925990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 26, 2012 · Synced Sep 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00925990 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →